Information  X 
Enter a valid email address

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

By BFN News | 08:40 AM | Tuesday 17 March, 2020

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1450p (from 1550p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t